Exo Imaging, Inc.


Exo is a company focused on advancing ultrasound technology through artificial intelligence and innovative workflow solutions. They develop FDA-cleared AI applications for ultrasound diagnosis, provide educational tools, and deploy POCUS programs to improve healthcare delivery. Their mission is to revolutionize point-of-care ultrasound with smarter, faster, and more accessible solutions.

Industries

health-care
medical
medical-device

Nr. of Employees

medium (51-250)

Exo Imaging, Inc.

1234 Innovation Drive, Tech City, TC 56789


Products

Handheld point-of-care ultrasound device with integrated AI

A portable handheld ultrasound device designed for bedside imaging with integrated AI applications for cardiac and lung assessment and real-time scanning assistance.

Cloud-based POCUS workflow and documentation platform

A software platform that centralizes image storage, automates documentation and QA workflows, and provides analytics to measure program performance and billing capture.


Services

Deployment and support of a cloud-connected workflow platform for point-of-care ultrasound programs, including documentation automation, QA, and rapid program rollout.

On-demand educational resources and coached training for clinicians and training programs to support adoption and competency in point-of-care ultrasound.

Collaborative research and partnership opportunities to evaluate and deploy AI tools for ultrasound, including assistance for clinical studies and validation.

Expertise Areas

  • Point-of-care ultrasound (POCUS) systems
  • AI-driven ultrasound image interpretation
  • Clinical workflow automation for imaging
  • POCUS education and training
  • Show More (2)

Key Technologies

  • Handheld ultrasound transducer technology
  • AI-based ultrasound image interpretation
  • Real-time automated sweep capture
  • Cloud-based POCUS workflow and documentation
  • Show More (2)

News & Updates

Exo has launched the first FDA-cleared point-of-care ultrasound AI for detecting pleural effusion and consolidation/atelectasis.

Exo announced a strategic partnership with Samsung Medison and welcomed Dr. Omar Ishrak to its board.

AI tools for heart failure with preserved ejection fraction (HFpEF) and cardiotoxicity have been added to Exo Iris.

New AI capabilities for hemodynamics and hypertension have been integrated into Exo Iris.

Exo introduced SweepAI™, a new AI-powered feature to enhance ultrasound imaging.

A new platform to rapidly deploy point-of-care ultrasound programs.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.